My only question is when is IBIO going to be mentioned or ink a deal? Lots of Ebola talk but never any mention of IBIO. They were'nt even mentioned in the 60min show. Their 7 employees seem to be on vacation lately. Most of the action seems to come from their subsidiaries and they get more mention than IBIO. There are a lot of competitors in the Ebola space who always seem to get press instead of IBIO/Caliber. Frustrating. Why is that? Don't they have an agressive enough lobbyist in DC.
$68M mkt cap. This has got to be a steal. Consider just $30k invested in ICPT in 2009 is now worth $11million. Think about that.
They both have the potential to be the vacine kings. IBIO has the patents for proprietary plant-based protein expression technologies. Their royalty partner Caliber Bio has the plant growing volume capability to supply the huge volumes that will be needed. Like INO, IBIO has got to be a huge winner. GLTA
Big buys coming in. This large volume is confirmation of higher prices to come.
If it follows what it did in march we'll see lower prices in the days to come.
Go ruin something else.
The trend has been down we all agree. Late in the day large buys came in from who knows who and reversed the trend. Something up or just manipulation. We wait and see. I've never been short.